AtaiBeckley (XTER:B72) Net Interest Margin (Bank Only) %


XTER:B72 AtaiBeckley Inc XTER:B72
54 GF Score
Price €4.50
GF Value €6.28
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is AtaiBeckley Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XTER:B72
54GF Score
AtaiBeckley Inc XTER:B72
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtaiBeckley (XTER:B72) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of €4.50 is trading 28.3% below its estimated GF Value™ of €6.28. GuruFocus considers AtaiBeckley to be Modestly Undervalued.

Key valuation signals for XTER:B72:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €6.28 vs. price of €4.50 (28.3% below fair value)
  • GF Score™: 54/100 with 6 warning signs

No single metric tells the full story. See the XTER:B72 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtaiBeckley Business Description

Other Exchanges ATAI:USA
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
54GF Score

Get the complete analysis for XTER:B72

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.50
Price
€6.28
GF Value